Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LYR motif-containing protein 9 (LYRM9) is a small, hydrophilic, nuclear-encoded protein found within mitochondria and is characterized by a conserved N-terminal leucine-tyrosine-arginine (LYR) motif[1][2]. Members of the LYRM family, including LYRM9, generally function as assembly factors, accessory subunits, or chaperones involved primarily in mitochondrial processes, including oxidative phosphorylation (OXPHOS), protein synthesis, and iron-sulfur cluster assembly[1][2]. Specifically, bioinformatic analysis predicts that LYRM9 interacts with the mitoribosome subunit MRPL57 as well as LYRM1, thereby contributing to the maturation or stabilization of the mitochondrial ribosome[1]. There is no evidence that LYRM9 acts as a direct target for any approved or investigational drugs, nor is it classified as a receptor, enzyme, transporter, or transcription factor. Its dysfunction has not been directly associated with a specific disease phenotype as of current literature, but related LYRM proteins are involved in various mitochondrial disorders[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LYR motif-containing protein 9 (LYRM9).